SAGE Therapeutics Expands Leadership Team With Key Appointments

CAMBRIDGE, Mass., Sept. 21, 2015 (GLOBE NEWSWIRE) — SAGE Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the following appointments:Anne Marie Cook joins SAGE as Senior Vice President, General CounselJim Doherty, Ph.D., is promoted to Senior Vice President of ResearchHeinrich Schlieker, Ph.D., joins SAGE as Senior Vice President of Technical OperationsRyan Arnold, D.O., joins SAGE as Vice President of Medical Affairs”These key strategic appointments will significantly strengthen our organizational capabilities as we build towards becoming a commercial-stage company developing multiple novel product candidates,” said Jeff Jonas, M.D., Chief Executive Officer of SAGE Therapeutics. “Their years of strategic planning, operational expertise and commercial experience will contribute greatly in our continued evolution as a leading innovator in the development of medicines…


Link to Full Article: SAGE Therapeutics Expands Leadership Team With Key Appointments